The CEO of Novo Nordisk was questioned about the high cost in the U.S. of Wegovy and Ozempic, the wildly popular diabetes and ...

Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new ... Replacing Ultra-Processed Foods in Diet Reduces Type ...

Two scenarios loom on the horizon, as the epidemic of diabetes surges across the country. Scene one: even more pressure on the U.S. economy due to costs that are now over $325 billion a year and ...

Savory snacks, processed meats, ready-to-eat meals and sugary or artificially sweetened beverages are the ultra-processed foods most likely to lead to Type 2 diabetes, a new study finds.

Diabetes is a medical condition that affects blood sugar levels. Normally, people’s bodies maintain the ideal blood sugar levels automatically. When a person has diabetes, their body fails to maintain ...

Blurred vision, dry mouth, and frequent bathroom use are common signs of diabetes. If you’re experiencing these early signs, speaking with a doctor can help you manage your condition.

Diabetes is a number of diseases that involve problems with the hormone insulin. There is no cure for diabetes. The warning signs of diabetes can be so mild that you don't notice them. That's ...

Ask anyone if they know someone who has diabetes. Almost everyone will say yes, because about 1 in 10 people in America have the disease. In five years, that number may rise to 5 in 10 ...

Diabetes can affect many parts of your body, including heart, kidneys, eyes, feet, and legs. Various complications are possible the longer you live with the condition and if you have high blood ...

If you live with type 1 or type 2 diabetes, you might assume you’re ineligible for life insurance or that your premium will be too expensive. However, people whose diabetes is well-managed can ...

Treating diabetic retinopathy (DR) is still a significant challenge for clinicians and remains a leading cause of blindness worldwide. NovaGo Therapeutics is developing a human antibody therapy ...